Although regular physical activity (PA) is a cornerstone of treatment for type 2 diabetes (T2D), most adults with T2D are sedentary. Randomized controlled trials (RCTs) have proven the effectiveness of PA behavioral interventions for adults with T2D but have rarely been conducted in healthcare settings. We sought to identify PA interventions that are effective and practical to implement in clinical practice settings. Our first aim was to use the valid Pragmatic-Explanatory Continuum Indicator Summary 2 (PRECIS-2) tool to assess the potential for future implementation of PA interventions in clinical practice settings. Our second aim was to identify interventions that effectively increased PA and glycemic control among the interventions in the top tertile of PRECIS-2 scores. We searched PubMed MED-LINE from January 1980 through May 2015 for RCTs of behavioral PA interventions coordinated by clinical practices for patients with T2D. Dual investigators assessed pragmatism by PRECIS-2 scores, and study effectiveness was extracted from original RCT publications. The PRECIS-2 scores of the 46 behavioral interventions (n = 13,575 participants) ranged from 3.0 to 4.8, where 5 is the most pragmatic score. In the most pragmatic tertile of interventions (n = 16) by PRECIS-2 scores, 30.8 and 31.3% of interventions improved PA outcomes and hemoglobin A1c, respectively. A minority of published evidence-based PA interventions for adults with T2D were both effective and pragmatic for clinical implementation. These should be tested for dissemination using implementation trial designs.
INTRODUCTION
Between 1980 and 2014, the prevalence of diabetes mellitus almost quadrupled [1] , and recent estimates suggest that one third of all Americans born after the year 2000 will develop diabetes [2] . Among adults, type 2 diabetes (T2D) accounts for over 90% of diabetes diagnoses [3] . T2D more than doubles the risk of cardiovascular disease, including myocardial infarction and stroke [4] [5] [6] [7] . Even if people with T2D do not develop cardiovascular disease or microvascular complications of T2D, they remain at increased risk for early mortality and morbidity, including disability and other functional problems [8, 9] .
To mitigate these serious risks and successfully manage T2D, a healthy lifestyle is important. In particular, regular physical activity (PA) is a cornerstone of T2D management due to its major health benefits [10] . Observational data have linked regular PA to improved all-cause mortality, lower rates of cardiovascular disease, lower rates of breast and colon cancer, improved symptoms of depression and anxiety, and better functional outcomes in people with and without T2D [11] . Data from randomized controlled trials (RCTs) of lifestyle interventions that included both PA and weight loss have also yielded better health outcomes, such as lower incidence of stroke, improved fitness, and improved mobility [12] [13] [14] .
Based on observational data, it also appears that healthcare costs are lower for people with T2D who report regular PA [15, 16] . For example, among patients with T2D whose health insurance provided a health club membership, those who attended health clubs at least twice weekly over 12 months had $1252 lower mean healthcare costs than patients with T2D who attended PA classes less than once weekly (P < 0.001) [15] . The potential cost savings of regular PA are particularly important given that the annual medical costs of T2D in the US were recently estimated at $176 billion in direct medical costs and $69 billion in reduced productivity [17] .
Based on the substantial benefits of PA, the American Diabetes Association, the American College of Sports Medicine, and the US Physical Activity Guidelines all recommend that people with diabetes engage in at least 150 min of moderate to vigorous intensity PA, such as brisk walking, as well as two to three bouts of resistance training each week [11, 18] . However, most patients with T2D do not meet these standards [19, 20] . In fact, people with T2D are less likely to engage in regular PA than their peers without diabetes, even though the majority of people with T2D recognize that regular PA is important [19, 20] . This disconnect between knowledge and action highlights the potential for implementing evidence-based interventions in clinical care settings to increase reach and address personal barriers to PA for patients with T2D.
Currently, delivery of evidence-based PA interventions for people with T2D is not common practice in most clinical care settings [21, 22] . One possible explanation for this is that large-scale interventions which improved PA were not fully integrated into clinical practice settings; thus, they are not easy to translate into real-world settings [12, 14] . Studying interventions which are clinically integrated is critically important because limited clinic resources pose challenges to the translation of effective PA interventions into primary care [23, 24] . Difficulties in bringing evidence-based interventions to clinical practice are not limited to diabetes and PA behavior-the field of implementation science has developed rapidly to address concerns that <10% of evidence-based interventions are implemented in real-world settings [25] .
There are valuable real-world alternatives to integrating interventions into clinical practice: community-based programs are able to deliver evidence-based interventions, often tailored to specific community needs. Community-based interventions have been translated broadly for the Diabetes Prevention Program, and economic analyses suggest that these programs are highly costeffective [26] . In contrast to diabetes prevention, there are more limited examples of communitybased programs independently delivering diabetes self-management separately from clinical practices [27] [28] [29] . The National Diabetes Education Program has sought to clarify the key roles that communities can play to support patients with diabetes in their self-management [30] , and a recent review summarizes how communities and clinical practices may collaborate to improve diabetes selfmanagement [29] . While the relevance of community-based programs for diabetes selfmanagement should not be ignored, the focus of this review will be on the delivery of evidencebased physical activity counseling programs into clinical practice. The rationale for focusing on programs integrated within clinical practices is because this provides the benefit of utilizing clinician's judgment to identify patients who may participate safely; clinics also have the potential to receive reimbursement for these programs through health insurance.
To address the limited translation of effective physical activity programs into clinical practices, stakeholders with experience in clinical care, healthcare financing, and clinical trial design developed a tool to help clinical trial designers plan RCTs to test the delivery of evidence-based interventions in pragmatic real-world settings, as compared with planning RCTs of interventions to test efficacy that should be delivered in more idealized research settings [31] . This measurement tool was named the PRagmatic Explanatory Continuum Indicator Summary (PRECIS) model. In 2015, >80 international trialists, clinicians, and policy-makers revised and validated an updated version: the PRECIS-2 model [32] . The PRECIS-2 model may serve two purposes-to inform future trial design and to allow researchers to assess the Breal-world applicability^of published studies [33] .
There is a lack of published information regarding the potential for clinical translation of effective PA interventions for patients with T2D [10] . To address this gap, the goal of this review is to identify existing effective and pragmatic PA interventions for patients with T2D that may be translated into clinical practice. Our specific aims are (1) to use the PRECIS-2 tool to assess the pragmatism for implementation of PA interventions into clinical practice settings and (2) to identify interventions that effectively increased PA and glycemic control, respectively, among interventions ranked in the highest tertile by PRECIS-2 for pragmatism. By addressing these aims, we hope to spur further study of the benefits and costs of implementing pragmatic and effective PA interventions for patients with T2D into diverse clinical care settings.
METHODS

Data sources and searches
Our study team developed an a priori set of relevant inclusion and exclusion criteria (Appendix Table 2 ). Generally, these criteria led us to include SYSTEMATIC REVIEWS RCTs that tested an intervention which included PA counseling for patients with T2D who were cared for in a clinical care practice. We required that PA counseling was conducted consistently for all patients in the intervention group. However, in keeping with real-world practice needs, we also included interventions that targeted additional T2D self-management behaviors, such as diet, medication adherence, and smoking cessation. Study interventions needed to be clinically integrated, which we defined a priori as regular bidirectional communication between the research and clinical care teams. Furthermore, for studies in which the intervention was delivered by a research team member rather than a clinical care team member, we required that the research team interventionists must be healthcare professionals (e.g., physicians, nurses, pharmacists, social workers, psychologists, or behavioral therapists) and that any face-to-face intervention visits must take place in a longitudinal clinical care setting, in order to ensure that this intervention had the potential for future translation into a clinical practice setting.
Study selection
Working with our library informatics staff, we developed a search strategy for behavioral interventions with a PA component targeted to patients with T2D. The PubMed MEDLINE database was considered to be a comprehensive source for our needs, given our interest in trials of behavioral interventions that were integrated into clinical care. Our complete literature search strategy included terms for behavioral interventions, PA and T2D (Appendix Fig. 4) .
One author (KAL) preliminarily screened the search results by reviewing the manuscript title and abstract. For this initial screen, we applied our eligibility criteria conservatively to select RCTs conducted among adults with T2D which utilized a self-management intervention that might possibly contain PA, including diet and weight loss interventions. After this initial screen, the remaining articles were reviewed independently in a secondary screen by dual raters (KAL, AGH, and/or IML). For this secondary screen, raters independently applied the study eligibility criteria (Appendix Table 2 ) to the full-text articles to identify qualifying RCTs. In instances of rater disagreement on whether a study met inclusion/exclusion criteria, these disagreements were resolved through discussion and arbitration by another coauthor, when necessary. When both raters felt that there was insufficient information to determine eligibility, we contacted the RCT authors for clarification.
Data extraction and quality assessment In order to rank interventions by their Brealworld^applicability [33, 34] , we rated each study in terms of pragmatism, as measured by PRECIS-2. PRECIS-2 contains nine domains ( Fig. 1) : participant eligibility criteria, participant recruitment, trial setting, organization of intervention delivery, flexibility of delivery, flexibility of adherence, participant follow-up, primary analysis, and relevance of primary outcome [32] . The details of the PRECIS-2 rating scale, including pragmatic and explanatory extremes of each domain, have been described extensively elsewhere [32] . We adapted an existing rating tool that was used to assess PRE-CIS domains in a prior review article [33] . Our rationale was that highly pragmatic clinical trials more closely mimic real-world circumstances in terms of design. As mentioned earlier, the PRECIS-2 model is a revised version of the original PRECIS tool designed by Thorpe et al. to provide a means of evaluating a study design in terms of pragmatism [31] . Because the PRECIS-2 tool is not the only tool to assess the translation potential for clinical trials, we also assessed other pragmatic factors based on the widely used Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework. RE-AIM was designed with the intention of increasing reporting on the robustness, translatability, and public health impact of healthcare-related trials [33, 34] . We identified important practical feasibility factors derived from the RE-AIM framework that are not represented in the PRECIS-2 domains. These practical feasibility factors that we identified include reports of participant engagement, adaptation/change of intervention, program sustainability, unintended effects of intervention, and monetary costs of intervention [32] [33] [34] . We adapted an existing RE-AIM rating tool that was used to assess these practical feasibility factors in a prior review article [33] . Scoring for both RE-AIM and PRECIS-2 factors was assessed from the perspective of a patient-centered medical home (PCMH), rather than a traditional primary care clinic, as the PCMH model of care is rapidly spreading [35] and provides a model for population health teams to deliver behavior change interventions more optimally than traditional primary care practices [36, 37] .
We also extracted study data according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards of patient population and study outcomes [38] . One author (KAL or IML) extracted the key contextual components of each study. To ensure uniformity, the same author extracted the information from all studies for each PRISMA criterion. In addition to the PRISMA standards, we further extracted data regarding other external validity factors that may relate to future implementation decisions, such as the level of training of interventionists, the clinical setting, whether PA tracking was incorporated, the use of electronic health/mobile health resources, and whether interventions effectively improved PA outcomes and HbA1c outcomes, respectively.
Data synthesis and analysis
For the studies that met our inclusion/exclusion criteria, each was scored independently for the PRECIS-2 domains and RE-AIM practical feasibility factors by at least two raters (KAL, IML, ALN, JCM, AGH). To ensure clarity of the scoring rubric and calibration of raters, the five raters performed two iterative cycles of review of other RCTs by the PRECIS-2 and RE-AIM practical feasibility factors. During the iterative cycles of review, any areas of discrepancy were resolved through team discussions with senior co-authors (JGR, ALD, REG). In addition, when dual rater scores differed by >1 point on any given PRECIS-2 domain/RE-AIM factor, the raters reassessed that domain/ factor together and came to consensus on scores that differed by no more than 1 point. A third rater arbitrated any ratings that still differed by >1 point.
For each intervention (n = 46), we averaged the raters' scores to calculate mean numerical scores for each domain/factor. We averaged the mean score of all nine PRECIS-2 domains to create a composite PRECIS-2 score that we used to rank the interventions by tertiles. Across all interventions, we also assessed the prevalence of reporting on practical feasibility factors and the mean score averaged across all practical feasibility factors.
We defined effective interventions as those that led to a statistically significant increase in a valid PA behavior outcome over the intervention period in the intervention group, as compared to the control group (P < 0.05). We also defined separately the interventions that improved HbA1c in the intervention vs. control groups (P < 0.05). A single author extracted the information on intervention effectiveness from the relevant publication, and a second author confirmed this information (KAL, IML).
We used logistic regression (SAS software version 9.4) to conduct a post hoc analysis of the relationship between PRECIS-2 scores and PA outcomes across all RCTs, considering the PRECIS-2 score as the independent variable and the PA outcome measure as the dichotomous dependent variable (yes/no for statistically significant change in PA). We used the identical method in a separate regression model to compare the relationship between PRECIS-2 and HbA1c outcomes across all RCTs.
RESULTS
The PubMed literature search revealed 4813 citations (Fig. 2) . After screening by title and abstract, 4121 articles were excluded, leaving 692 full-text articles 
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that were considered for inclusion. Of these, 651 did not meet the study inclusion criteria. The most common reasons for exclusion were supervised PA (183), lack of clinical integration (110), and study design other than RCT (92). The final RCTs selected (n = 38) represented 46 independent interventions, as some trials tested >1 intervention [14, . The final RCTs selected were published between 1996 and 2015, as we did not identify any articles meeting our inclusion criteria that were published from 1980 to 1995.
PRECIS-2 scores
The composite PRECIS-2 score for each of the 46 interventions ranged from 3.0 to 4.8. The top tertile of interventions (n = 16) had composite PRECIS-2 scores ≥4.08. Mean scores varied across the nine PRECIS-2 domains: we found less pragmatic scores for PRECIS-2 domains of organization The majority of interventions studied (52.9%) reported effective improvements in PA outcomes. However, in the top tertile of interventions (n = 16) ranked by PRECIS-2 score, only 30.8% of interventions reported effective improvements in PA outcomes (Fig. 3a) . As illustrated in Fig. 3a , our post hoc analysis suggested a possible inverse relationship between level of pragmatism by PRECIS-2 and PA effectiveness outcomes, albeit not statistically significant (P = 0.06). Just over one third of interventions studied (37.5%) effectively decreased HbA1c. In the top PRECIS-2 tertile, 31.3% of interventions effectively decreased HbA1c (Fig. 3b) . The relationship between PRECIS-2 score and HbA1c effectiveness was not significant (P = 0.92).
Practical feasibility scores derived from RE-AIM The majority of studies (62%) did not report on any of the practical feasibility factors that we assessed and thus received the lowest score of 1. Of the 38% of studies that reported on at least one practical feasibility domain, rates of reporting were highest for participant engagement (32%) and monetary costs of intervention (8%) (Appendix Fig. 5 ). No study authors reported on adaptation/change of the intervention to accommodate to clinical site needs or on unintended effects of the intervention. The composite practical feasibility for each intervention (n = 46) ranged from 1 to 2.2 on a possible five-point scale.
Intervention characteristics
Given this review's focus on identifying RCTs of therapies that may be translated into clinical practice, we report on both the typical PRISMA intervention characteristics as well as additional factors related to external validity (see Table 1 for top tertile and Appendix Table 3 for bottom two tertiles). Of the 46 interventions included, 38% used PA tracking and/or feedback methods as an intervention strategy. The PA tracking/ feedback methods used were diverse, ranging from web-based communication to one-on-one visits with study personnel to review PA diaries. Participants were given pedometers, accelerometers, or other unspecified Bactivity monitors^to use for PA tracking in 21% of interventions. Only 11% of interventions utilized electronic health (eHealth) modalities such as the internet or mobile phones as part of the intervention. Studies took place in more than 10 different countries between 1990 and 2015, and the study duration ranged from 2.8 months to 8 years.
Risk of bias
For each of the seven areas within the Cochrane risk of bias tool [73] , two authors (IML and AGH) independently assessed the risk of bias for each included study. We resolved differences in reviewer ratings through discussion. In each of the seven categories, less than 6% of studies had a high risk of bias (Appendix Fig. 6 ). As no studies had a high risk of bias on all seven categories, we did not exclude any based on these bias risk assessments.
CONCLUSIONS
This systematic review identified behavioral interventions that are feasible to implement in clinical practice settings and that effectively increased PA for people with T2D. The range of PRECIS-2 scores from 3.0 to 4.8 across the 46 interventions studied demonstrates a range of pragmatism from modestly pragmatic to highly pragmatic. It is of possible concern that the level of study pragmatism tended to be inversely related to improvements in PA, albeit of borderline statistical significance (P = 0.06). This suggests that PA interventions conducted in more real-world settings may be less effective when compared to studies in more idealized and heavily resourced contexts. Nevertheless, among the behavioral interventions that we ranked in the most pragmatic tertile by composite PRECIS-2 scores, four interventions by SperlHillen et al. [39] , Christian et al. [50] , Di Loreto et al. [53] , and Glasgow et al. [54] effectively improved PA outcomes-two of these four effective PA interventions also improved HbA1c outcomes [31, 45] .
A key question that emerges from this review is how do we identify the moderators and key components of successful interventions that are highly pragmatic and translational? The existing literature on predictors of effective PA interventions SYSTEMATIC REVIEWS TBM page 6 of 22 [74] [75] [76] . What remains unclear is how these evidence-based techniques may be optimally implemented with pragmatic approaches in clinical care. This review was not a meta-analysis and cannot statistically dissect the factors that moderated success among the four interventions in the top tertile by PRECIS-2 scores that also improved PA outcomes. Nevertheless, we did note some common themes among the four highly pragmatic and effective interventions that may be instructive. The majority of these interventions used PA tracking that allowed PA intervention content to be tailored to individual activity levels; interventions also tended to be delivered over a duration of 12 months or longer.
Other than the regularity of PA tracking/feedback, the intervention approaches were fairly diverse, but commonly used simple tools to help participants and healthcare providers jointly identify and track behavior patterns and behavioral predictors of PA levels. These tools included a simplified form of in-person motivational interviewing [53] , a computerized self-assessment that automatically generated individualized and tailored feedback [50, 54] , or the use of a Bconversation map^of diabetes self-management challenges [39] . While we already know much about what factors are necessary for effective interventions, we need to better understand how to ensure that these techniques are effective when delivered pragmatically in clinical settings. For example, both the effectiveness on PA/HbA1c outcomes and the pragmatism of Sperl-Hillen's intervention were superior when delivered 1:1 rather than using a group visit delivery format [39] . This finding stands in stark contrast to the existing literature that suggests that group and individual diabetes self-management education are equivalent [77] and suggests that further pragmatic trials to assess the comparative effe ct ive ness of individu al a nd grou p selfmanagement education of T2D in usual practice may be warranted. Sperl-Hillen's findings from their pragmatic trial may suggest that individual interventions to improve T2D self-management are especially important when individual motivators and barriers are more heterogeneous, but another possibility is that this was a chance finding.
As another example, in the study conducted by De Greef et al., the effects of the same behavioral intervention were significantly different based on who delivered the intervention and the dose of intervention-a trained behavioral expert providing counseling over three separate 90-min sessions effectively increased PA but a primary care clinician providing the same counseling content over three separate 15-min clinic visits did not increase PA [49] . Other review articles have lamented the lack of data on fidelity of intervention delivery in RCTs and have noted this as a limitation to identifying key moderators of PA interventions [76] . The highly pragmatic and effective intervention by Di Loreto et al. that we studied in the present review balanced the competing clinical demands and fidelity to intervention techniques by condensing several effective behavioral change techniques into a simple yet tailored counseling checklist which identified enjoyable and appropriate PA options at the individual level and encouraged patients to continue with these programs through the use of social support, problem-solving, and PA tracking [45] . Another important component of this intervention that used the counseling checklist was to deliver the intervention directly after a 30-min clinical in-person assessment of T2D that allowed the opportunity to address competing clinical concerns immediately prior to delivering the behavioral counseling [53] .
In recent years, the proliferation of mobile phone users coupled with the increasing popularity of PA tracking devices that sync with phones/ computers have provided novel opportunities for eHealth applications. Diabetes researchers have also been encouraged by the promise of eHealth to enhance the reach and effectiveness of T2D self-management interventions, including PA interventions [78, 79] . Thus, we were intrigued to notice that only 6 of the 46 interventions that we studied utilized any measures related to eHealth [50, 54, 55, 64, 80] . However, it is important to note that most of the interventions we studied were conducted before the recent explosion of smartphone and wearable technology for tracking PA [81, 82] ; in the coming years, these percentages may change considerably as more researchers begin to embrace eHealth. Our review covered a broad range of publication dates (1996-2015), which introduces a concern for any secular PA trends over that timeframe. PA guidelines for patients with type 2 diabetes over that time span did remain relatively unchanged, promoting PA of 30 min of moderate intensity on most days of the week (≥120 min/week) in 1996 and recommendations of 150 min of weekly moderate intensity activity in 2015. Perhaps more importantly, the increase in PA tracking use over the past decade may have allowed patients' greater ability to simply self-monitor their PA levels. While they represented the minority of interventions that we studied, 100 and 40% of the aforementioned eHealth interventions improved PA and HbA1c outcomes, respectively. Although the eHealth interventions we studied uniformly improved PA outcomes, it is interesting to note that only two of the six eHealth interventions that we studied were in the top tertile by PRECIS-2 scores. To improve the pragmatism of future PA interventions using eHealth methods, one opportunity may be to SYSTEMATIC REVIEWS TBM page 10 of 22 enhance the linkage of PA tracking to existing electronic medical records [83] . This linking would allow clinicians and patients to more readily monitor physical activity levels and communicate regarding new activity goals. As wearable PA tracking devices and technology use continuously expand [81, 82] , this is an area that will see growth and constant adaptations year after year.
To enhance the translation of effective studies into real-world settings, it is also important for researchers to report on outcomes other than effectiveness that will influence future implementation. The PRECIS-2 tool incorporates many outcomes that predict the future implementation of interventions, but we also assessed certain additional practical feasibility factors derived from RE-AIM, such as costs and program sustainability, that are not measured by the PRECIS-2 tool. It was concerning that almost no studies reported on these dimensions important to potential adopters of PA interventions in clinical settings. As in this review, the other literature assessing the feasibility to translate interventions into clinical practice found that authors severely underreport important measures from RE-AIM and PRECIS-2, such as intervention costs, BReach^in RE-AIM that corresponds to the PRECIS-2 domains of eligibility and recruitment, as well as the organizational burden of the staff, training, resources, and infrastructure required to deliver an intervention [33, [84] [85] [86] [87] . Without transparent reporting on the cost, adaptations made, and sustainability of PA interventions, it will be impossible for health systems to determine the value of these interventions for their clinical populations with T2D. Recently, the Standards for Reporting Implementation Studies (StaRI) initiative developed a checklist of items to report on for implementation science research [88] ; with the future adaptation of these standards by researchers and journal editors, transparent reporting on factors relevant to stakeholders should allow health systems to more readily identify feasible programs for adoption.
This systematic review is innovative in its approach to categorize effective PA-related interventions for individuals with T2D by their level of pragmatism. One limitation, however, is that the variability in the number of participants in each study may have led us to underestimate the number of studies that were effective for PA or HbA1c outcomes. To mitigate this limitation, our a priori criteria were set to exclude pilot studies with <40 participants or that reported <80% power to address the primary RCT outcome. Also, because this is not a meta-analysis, we could not determine the moderators of effectiveness in the interventions that were both highly pragmatic and improved PA outcomes. Regarding our assessment of the PRECIS-2 criteria, we conducted scoring from the perspective of a PCMH rather than a standard primary care clinic. This is a limitation, as it would be more challenging for clinics without a population health team to implement interventions that rely on staff contact outside of faceto-face clinician visits. However, two of the effective interventions in the top tier of pragmatism would be pragmatic to deliver in standard primary care clinics, as well as PCMH models, as they did not rely on a population health team for intervention delivery [50, 53] . Finally, we only assessed interventions that were clinically integrated; a prior review has identified important strategies for partnership between clinics and community organizations to improve diabetes selfmanagement [29] , and future research should identify pragmatic and effective interventions that can be delivered in partnership with community organizations.
If models of healthcare continue to shift from feefor-service to patient-centered medical homes and accountable care organizations [37, 89] , the emphasis to deliver high-value care that improves important health outcomes should continue to grow. An additional trend that may further the translation of PA and other behavioral interventions into clinical practice is the recent Medicare approval of Chronic Care Management funding codes in 2015 to reimburse clinical counseling and coordination of care that is delivered outside of face-to-face clinic visits [90] . Health system administrators may consider implementing the interventions that we identified as effective and pragmatic when the costs are deemed reasonable and the characteristics of the trials are a good match with their health systems. To enhance implementation further, the interventions that we identified as both pragmatic and effective merit further study in diverse real-world settings. In addition to reporting effectiveness, such future RCTs of PA interventions in real-world settings should report on intervention fidelity and adaptation, in order to inform the assessment of intervention moderators. Perhaps most importantly, such future RCTs of PA interventions in real-world settings must report on key practical feasibility factors that have been typically ignored, including intervention costs and sustainability.
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